Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Pimobendan is an inhibitor of phosphodiesterase 3 (PDE3; IC50 = 0.32 μM for guinea pig cardiac enzyme) that is selective for PDE3 over PDE1, PDE2, and PDE4 (IC50s = >30 μM).1 It is also a calcium sensitizer, decreasing the concentration of calcium required for half-maximal contractile force in isolated, skinned porcine ventricular fibers. Pimobendan increases the force of contraction in electrically-stimulated isolated guinea pig papillary muscles with an EC50 value of 6 μM, indicating positive inotropic effects.2 It increases survival time in dogs with congestive heart failure due to myxomatous mitral valve disease when administered in combination with angiotensin-converting enzyme inhibitors and furosemide (Item No. 17273).3 Formulations containing pimobendan have been used in the treatment of heart failure in dogs.
WARNING This product is not for human or veterinary use.
1. The novel cardiotonic agent EMD 53 998 is a potent "calcium sensitizer". J. Cardiovasc. Pharmacol. 18(1), 17-27 (1991).
2. Relation of positive inotropic and chronotropic effects of pimobendan, UD-
3. Efficacy of pimobendan on survival and reoccurrence of pulmonary edema in canine congestive heart failure. J. Vet. Med. Sci. 79(1), 29-34 (2017).